CAPS Trial: Cannabidiol Youth Anxiety Pilot Study (open-label completed, 2020) This study ran for 12 weeks and involved 31 participants aged 12-25 who were diagnosed with severe anxiety disorders and failed to respond to cognitive behavioural therapy (CBT) sessions,...
![Lambert Initiative for Cannabinoid Therapeutics: Cannabinoids and Anxiety](https://nubupharma.com/wp-content/uploads/2024/06/pexels-mccutcheon-3676962-scaled-1.jpg)